MAM
AVEO

MPM Asset Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

MPM Asset Management’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-137,212
Closed -$2.51M – 13
2013
Q4 		$2.51M Sell
137,212
-83,684
-38% -$1.68M 0.81% 11
2013
Q3 		$4.55M Hold
220,896
– – 1.28% 10
2013
Q2 		$5.52M Buy
+220,896
New +$9.44M 2.44% 7

Other funds holding AVEO

Baupost Group
Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

MPM Asset Management's AVEO Position: Q1 2014 in Review

MPM Asset Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2014, closing a stake of 137,212 shares — an estimated $2.51M sold.

MPM Asset Management first reported a position in AVEO in Q2 2013 and held it in 3 quarters. The position peaked at $5.52M in Q2 2013. 68 funds tracked by Wall St. Rank hold AVEO as of Q1 2014.

  • MPM Asset Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2014 after selling out during the quarter.
  • MPM Asset Management sold 137,212 AVEO Pharmaceuticals, Inc. shares in Q1 2014, an estimated $2.51M.
  • MPM Asset Management first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 3 quarters.
  • MPM Asset Management's AVEO Pharmaceuticals, Inc. position peaked at $5.52M in Q2 2013.
  • 68 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2014.

Based on MPM Asset Management's 13F filing for Q1 2014, filed 8 May 2014.